| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ADCY10 | CNR1 | ENSOARP00000013180 | ENSOARP00000021470 | Adenylate cyclase 10. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.900 |
| ADCY10 | GCH1 | ENSOARP00000013180 | ENSOARP00000022652 | Adenylate cyclase 10. | GTP cyclohydrolase 1. | 0.800 |
| ADCY10 | ITPA | ENSOARP00000013180 | ENSOARP00000004259 | Adenylate cyclase 10. | Inosine triphosphate pyrophosphatase; Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions; Belongs to the HAM1 NTPase family. | 0.901 |
| ADCY10 | LOC101108001 | ENSOARP00000013180 | ENSOARP00000001255 | Adenylate cyclase 10. | Guanylate cyclase domain-containing protein. | 0.906 |
| ADCY10 | MOCS1 | ENSOARP00000013180 | ENSOARP00000000484 | Adenylate cyclase 10. | Molybdenum cofactor synthesis 1. | 0.800 |
| ADCY10 | NME6 | ENSOARP00000013180 | ENSOARP00000001136 | Adenylate cyclase 10. | Nucleoside diphosphate kinase. | 0.698 |
| ADCY10 | NTPCR | ENSOARP00000013180 | ENSOARP00000003562 | Adenylate cyclase 10. | Nucleoside-triphosphatase, cancer-related. | 0.900 |
| ADCY10 | NUDT2 | ENSOARP00000013180 | ENSOARP00000009971 | Adenylate cyclase 10. | Nudix hydrolase 2; Belongs to the Nudix hydrolase family. | 0.900 |
| ADCY10 | PRKACA | ENSOARP00000013180 | ENSOARP00000006933 | Adenylate cyclase 10. | cAMP-dependent protein kinase catalytic subunit alpha; Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis. Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP. RORA is activated by phosphorylation. Required for glucose- mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts. Involved in the [...] | 0.743 |
| ADCY10 | PRKACB | ENSOARP00000013180 | ENSOARP00000014812 | Adenylate cyclase 10. | Protein kinase cAMP-activated catalytic subunit beta; Belongs to the protein kinase superfamily. | 0.743 |
| CNR1 | ADCY10 | ENSOARP00000021470 | ENSOARP00000013180 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Adenylate cyclase 10. | 0.900 |
| CNR1 | LOC101108001 | ENSOARP00000021470 | ENSOARP00000001255 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Guanylate cyclase domain-containing protein. | 0.900 |
| GCH1 | ADCY10 | ENSOARP00000022652 | ENSOARP00000013180 | GTP cyclohydrolase 1. | Adenylate cyclase 10. | 0.800 |
| GCH1 | ITPA | ENSOARP00000022652 | ENSOARP00000004259 | GTP cyclohydrolase 1. | Inosine triphosphate pyrophosphatase; Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions; Belongs to the HAM1 NTPase family. | 0.932 |
| GCH1 | LOC101108001 | ENSOARP00000022652 | ENSOARP00000001255 | GTP cyclohydrolase 1. | Guanylate cyclase domain-containing protein. | 0.800 |
| GCH1 | MOCS1 | ENSOARP00000022652 | ENSOARP00000000484 | GTP cyclohydrolase 1. | Molybdenum cofactor synthesis 1. | 0.916 |
| GCH1 | NME6 | ENSOARP00000022652 | ENSOARP00000001136 | GTP cyclohydrolase 1. | Nucleoside diphosphate kinase. | 0.831 |
| GCH1 | NUDT2 | ENSOARP00000022652 | ENSOARP00000009971 | GTP cyclohydrolase 1. | Nudix hydrolase 2; Belongs to the Nudix hydrolase family. | 0.882 |
| ITPA | ADCY10 | ENSOARP00000004259 | ENSOARP00000013180 | Inosine triphosphate pyrophosphatase; Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions; Belongs to the HAM1 NTPase family. | Adenylate cyclase 10. | 0.901 |
| ITPA | GCH1 | ENSOARP00000004259 | ENSOARP00000022652 | Inosine triphosphate pyrophosphatase; Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions; Belongs to the HAM1 NTPase family. | GTP cyclohydrolase 1. | 0.932 |